Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Abstract

Assessment of fibrosis stage grants prognostic value beyond biochemical treatment response at 1 year. This highlights the need to incorporate fibrosis stage in individual risk stratification in patients with PBC, partly to identify those that may derive benefit from novel therapies.